Researchers at CEDAR, the Cancer Early Detection Advanced Research Center in the OHSU Knight Cancer Institute, have engineered material that replicates human bone tissue. The material is being used to explore disease processes such as the origin of metastatic tumors in bone, and as a treatment for large bone injuries. (OHSU/Joe Rojas-Burke)

Avathamsa Athirasala, M.Sc.Eng. (left) and Luiz Bertassoni, D.D.S., Ph.D. (OHSU/Joe Rojas-Burke)

Trial participant Bill Westmoreland takes part in a class in July 2019 at OHSU. The class is part of a NIH-funded clinical trial testing two types of exercise--tai chi versus strength training--as a means to prevent falls and injuries in men who've received anti-androgen therapy for prostate cancer. (OHSU/Joe Rojas-Burke)

Brian Fawkes, trial participant, (left) is guided by trainer Kimi Daniel during a class in July 2019 at OHSU. The class is part of a NIH-funded clinical trial testing two types of exercise--tai chi versus strength training--as a means to prevent falls and injuries in men who've received anti-androgen therapy for prostate cancer. (OHSU/Joe Rojas-Burke)

Gordon Mills, M.D., Ph.D., at the Knight Cancer Research Center in Portland, September 13, 2018. (OHSU/John Valls)

Knight Scholars touring the Knight Cancer Research Building in Portland, July 2019. (OHSU/Joe Rojas-Burke)

Knight Scholars students at the Knight Cancer Research Building in Portland, July 2019. (OHSU/Joe Rojas-Burke)

The Center for Experimental Therapeutics at the OHSU Knight Cancer Institute provides expertise in pharmacology, toxicology and chemistry for new drug development, along with access to chemical compounds, high-throughput screening services and a wide range of model test systems. (OHSU/Christine Torres Hicks)

Shivaani Kummar, M.D., head of the division of hematology and medical oncology in the OHSU School of Medicine, and Sanjay Malhotra, Ph.D., right, are co-directors of the Knight Cancer Institute’s Center for Experimental Therapeutics. Malhotra is a professor in the departments of cell, developmental and cancer biology and oncological sciences in the OHSU School of Medicine. (OHSU/Christine Torres Hicks)

Kathy Hart is on the path to recovery following a rare skin and musculature condition that ultimately revealed stage 3 uterine cancer. She has a good prognosis with the benefit of complex, multidisciplinary care at OHSU. (OHSU/Christine Torres Hicks)